Home Tags Cloevis

Tag: Cloevis

Company developing cataract-fighting drug wins 2011 Enterprize competition

A company pioneering a drug to delay cataracts from forming or slow their growth has won this year's $100,000 Enterprize competition. Adelaide-based Calpain Therapeutics' victory was announced earlier this month by University of Queensland Business School, which has run Australia's richest business-plan contest since 2000.

Adelaide startup takes out UQ Business School’s $100,000 Enterprize competition

On World Sight Day, judges of the University of Queensland (UQ) Business School’s $100,000 Enterprize competition finals voted resoundingly for an innovation that could control the world’s single largest cause of blindness – cataract, a clouding of the eye’s lens among older populations. Calpain Therapeutics, an Adelaide startup that has developed a drug that can slow the onset of cataract, won the nation’s richest business plan competition, ahead of four others shortlisted.

The UQ Business School has announced its Enterprize 2011 finalists

The University of Queensland Business School has announced the five finalists of its 2011 Enterprize competition. A drug to the delay the progression of cataracts, a stopping corrosion low-cost chemical mix, an environment friendly fabrication technology, an online international patent search tool and an internet hub that hosts competitions to build predictive models are the five ideas behind the finalists of the business competition.
Subscribe to the Newsletter Over 30K subscribers

FREE BUSINESS TOOLS

FREE BUSINESS TOOL

Need cash for your startup or innovation? Here’s the Ultimate Grant...

Have a new business? Are you developing something AWESOME! Well, you're going to need some funding. Here are 12 resources available to people like you, right now.

INFOGRAPHICS

New Zealand’s Xero eyes US IPO, further disruption as subscribers increase...

Xero recently held its annual meeting in Wellington, during which the company revealed some interesting details about its future. As has been widely suspected, the...

OPINIONS & ADVICE